Nano Technological Drug Release Approaches for the Treatment of Eye Diseases: Myth, Reality or Challenge?

@inproceedings{Formica2018NanoTD,
  title={Nano Technological Drug Release Approaches for the Treatment of Eye Diseases: Myth, Reality or Challenge?},
  author={Mar{\'i}a Lina Formica},
  year={2018}
}
Drug ophthalmologic administration is a great challenge for pharmaceutical technology due to ocular barriers limit drugs access to action site. The common routes of administration are topical instillation or sub conjunctival injection for the treatment of anterior segment of eye; while, for the administration of drugs to the posterior segment, the most common routes include systemic dosing, periocular or intravitreal injections and, to a lesser extent, topical instillation. More than 90% of… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 13 REFERENCES

Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide

RS Kadam, P Tyagi, F EdelhauserH, UB Kompella
  • International Journal of Pharmaceutics
  • 2012

Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration

M Abrishami, S Zarei Ghanavati, D Soroush, M Rouhbakhsh, M RJaafari
  • Retina (Philadelphia Pa)
  • 2009
VIEW 1 EXCERPT